Vanessa
Roldan Schilling
Catedraticos de Universidad Vinculados H.V.Arrixaca
![Foto de Vanessa](/img/uploaded/aab593d7615a80d42da1c23d7d2bc16b.jpeg)
![Foto de Hospital General Universitario Reina Sofía](/img/noimage_org.png)
Hospital General Universitario Reina Sofía
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Reina Sofía (9)
2023
-
Factor XI in Carriers of Antiphospholipid Antibodies: Elevated Levels Associated with Symptomatic Thrombotic Cases, While Low Levels Linked to Asymptomatic Cases
International Journal of Molecular Sciences, Vol. 24, Núm. 22
2022
-
Current trends on antithrombotic therapy
REC: CardioClinics
2018
-
Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA 2 DS 2 -VASc and HAS-BLED scores using multiple biomarkers
Annals of Medicine, Vol. 50, Núm. 1, pp. 26-34
-
Assessment of two contact activation reagents for the diagnosis of congenital factor XI deficiency
Thrombosis Research, Vol. 163, pp. 64-70
2017
-
High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: Results from the Yecla study
Haemophilia, Vol. 23, Núm. 6, pp. e488-e496
2016
-
Repercusiones en la posología de los anticoagulantes orales no antagonistas de la vitamina K por las variaciones de la función renal de los pacientes con fibrilación auricular e insuficiencia cardiaca aguda reciente
Revista Espanola de Cardiologia, Vol. 69, Núm. 2, pp. 134-140
2011
-
Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: A pilot study
Thrombosis Research
-
Prevention of venous thromboembolism in patients with cancer in Spain
Journal of Coagulation Disorders, Vol. 3, Núm. 1, pp. 64-68